NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
Key Details
- 1NIH total investment in the AI4AD project now totals $30.7 million, with a new $12.6 million award supporting the next phase (AI4AD2).
- 2AI4AD2 unites 10 investigators and 23 co-investigators from 10 institutions.
- 3The project integrates whole-genome sequencing, brain imaging, cognitive tests, and biological data from over 58,000 participants across 57 cohorts.
- 4New 'genomic language models' will analyze genomic sequences for disease-associated DNA changes.
- 5AI tools developed previously demonstrated >90% accuracy detecting Alzheimer's markers from over 80,000 brain scans.
- 6The initiative also focuses on inclusive, multi-ancestry research and genome-guided drug discovery.
Why It Matters
This large-scale effort could redefine Alzheimer's diagnosis and treatment by combining AI-powered brain imaging analysis with genomics, enabling precision medicine approaches. It also addresses diversity and reproducibility issues in neuroimaging and biomarker AI research.
Source
EurekAlert
Related News
•EurekAlert
Researchers Develop All-Optical Synapse for Neuromorphic Imaging Systems
A new artificial synapse, controlled entirely by light, enables in-sensor neuromorphic processing for more efficient and noise-resistant imaging systems.
•EurekAlert
AI-Simulation Approach Achieves 90% Faster Brain MRI with Minimal Data
A simulation-based AI method can reconstruct brain MRI scans with only 10% of the usual data, greatly reducing scan times.
•EurekAlert
Mayo Clinic Showcases Imaging AI and Early Cancer Detection Advances at ASCO 2026
Mayo Clinic researchers will present over 30 studies at ASCO 2026, highlighting new advances in imaging AI, data science, and early cancer detection.